Pan-Cell Death Protein Signature as a Novel Diagnostic and Prognostic Biomarker for Intracerebral Hemorrhage
Journal of Proteome Research · 2026
DOI: 10.1021/acs.jproteome.5c00870 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Proteome Research, 2026. Verfasst von Tianhong Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Kunming Jinning District People's Hospital, No. 36 Juqiao Road, Kunyang Subdistrict, Kunming 650000, China. Hauptthemen laut MEDLINE: Cerebral Hemorrhage. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Kunming health research project, Scientific research fund project of Yunnan Provincial Department of Education, Yunnan Science and technology program.
Abstract (Originalsprache)
Intracerebral hemorrhage (ICH) remains a major cause of morbidity and mortality, with no rapid blood-based biomarkers available to assess secondary brain injury. This study aimed to identify a circulating pan-cell death protein signature for diagnosing and prognosing ICH. We prospectively enrolled 60 ICH patients and 60 age/sex-matched healthy controls, collecting plasma at defined time points after ICH onset. Using Olink proteomics, we identified 13 apoptosis-related proteins with significant dysregulation. Four key proteins─TLR4, ALOX15, FTL, and BMF─were validated through ELISA and RT-qPCR, showing good diagnostic performance (AUCs 0.799-0.835). A multiprotein logistic model demonstrated excellent diagnostic accuracy (AUC = 0.955). These biomarkers correlated with clinical severity and prognosis, including hematoma volume and a 90-day modified Rankin Scale (mRS). Additionally, animal models confirmed time-dependent upregulation of TLR4 in astrocytes. This pan-cell death protein signature provides valuable insights into ICH pathology and offers a promising tool for early diagnosis, risk stratification, and therapeutic targeting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Kunming Jinning District People's Hospital, No. 36 Juqiao Road, Kunyang Subdistrict, Kunming 650000, China.
- Department of Neurosurgery, The First Hospital of Kunming (Affiliated Calmette Hospital of Kunming Medical University), Kunming 650224, China.
ORCID-Profile: Nan Zhao
Förderung
- Kunming health research project
- Scientific research fund project of Yunnan Provincial Department of Education
- Yunnan Science and technology program
Zitieren
APA
Wang, T., Huang, W., Li, Z., Cao, Z., Pu, K., Shao, D., Wu, J., Li, J., & Zhao, N. (2026). Pan-Cell Death Protein Signature as a Novel Diagnostic and Prognostic Biomarker for Intracerebral Hemorrhage. Journal of Proteome Research. https://doi.org/10.1021/acs.jproteome.5c00870
Vancouver
Wang T, Huang W, Li Z, Cao Z, Pu K, Shao D, et al. Pan-Cell Death Protein Signature as a Novel Diagnostic and Prognostic Biomarker for Intracerebral Hemorrhage. Journal of Proteome Research. 2026. doi:10.1021/acs.jproteome.5c00870
BibTeX
@article{Wang2026,
author = {Wang, Tianhong and Huang, Wenbiao and Li, Zhe and Cao, Zhiwei and Pu, Kuairong and Shao, Dongchuan and Wu, Jun and Li, Jin and Zhao, Nan},
title = {Pan-Cell Death Protein Signature as a Novel Diagnostic and Prognostic Biomarker for Intracerebral Hemorrhage},
journal = {Journal of Proteome Research},
year = {2026},
doi = {10.1021/acs.jproteome.5c00870}
}
EUVIMED